Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab. [electronic resource]
Producer: 20060130Description: 1525-30 p. digitalISSN:- 1462-0324
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Humans
- Infliximab
- Magnetic Resonance Imaging -- methods
- Male
- Middle Aged
- Severity of Illness Index
- Spondylitis, Ankylosing -- drug therapy
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.